Sanofi Victorious In Arava Antitrust Class Action
Sanofi-Aventis U.S. LLC has won an antitrust class action filed by a drug wholesaler claiming Sanofi had submitted a sham citizen petition to delay release of generic versions of an arthritis...To view the full article, register now.
Already a subscriber? Click here to view full article